Our Foundation

Building the Future of AI-Powered Drug Discovery

Apoptra Discovery is a UK-based biotechnology and artificial intelligence company developing next-generation computational platforms for drug discovery. We integrate machine learning, computational biology, structural biology and multi-omics analysis to accelerate therapeutic target identification, biomarker discovery and precision medicine.

UK Registered

Company

Cardiff, Wales

Headquarters

Focus AI Drug Discovery

Founded

Who We Are

Building the Future of AI-Powered Drug Discovery

Apoptra Discovery Limited is a UK biotechnology and artificial intelligence company focused on transforming drug discovery through computational biology, machine learning and precision medicine. Our mission is to accelerate therapeutic innovation by combining scientific expertise with advanced AI technologies.

Our research philosophy combines explainable artificial intelligence with rigorous biological validation. By integrating multi-omics data, structural biology and predictive modelling, we generate insights that help researchers prioritise therapeutic targets with greater confidence.

Our Principles

Core Tenets of Our Innovation

01

02

03

Scientific Rigor

Interpretable Models

Collaborative Integrity

Every model and analysis is grounded in peer-reviewed biological principles and validated against robust datasets. We prioritize accuracy and reproducibility in all our work.

We build transparent AI solutions that explain their reasoning, empowering scientists to understand and trust the insights derived from complex data.

Partnerships are built on mutual respect and shared scientific goals. We integrate seamlessly with academic and industry teams to accelerate discovery.

Partner with Our Scientific Team

Accelerate your research initiatives with our expertise in computational biology and interpretable AI for drug discovery.